← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 6, 2022Last known activity
Jul 8, 2025
Timeline
2010s
- Jan 1, 2019
Cybin Therapeutics Inc.— Founded
2020s
- Aug 28, 2023
Small Pharma Ltd— Acquired
Drugs by trial phase (4 distinct, 9 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 1 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (13)
- NCT06793397Lead sponsorPhase 3Jul 8, 2025
- NCT06793397OfficialPhase 3Jul 8, 2025
- NCT06605105OfficialPhase 3Feb 23, 2025
- NCT06605105Lead sponsorPhase 3Feb 23, 2025
- NCT06564818OfficialPhase 3Nov 30, 2024
- NCT06564818Lead sponsorPhase 3Nov 30, 2024
- NCT06051721Study directorPhase 1/Phase 2Jan 6, 2024
- NCT06051721Lead sponsorPhase 1/Phase 2Jan 6, 2024
- NCT06051721OfficialPhase 1/Phase 2Jan 6, 2024
- NCT05594667Lead sponsorPhase 2Dec 15, 2022
- NCT05385783OfficialPhase 1/Phase 2Jul 6, 2022
- NCT05385783Lead sponsorPhase 1/Phase 2Jul 6, 2022
- NCT05385783Study directorPhase 1/Phase 2Jul 6, 2022
Details
- Founded
- Vancouver, BC, CA Jan 1, 2019
- Last known activity
- Jul 8, 2025